Preston D. Moore

1.1k total citations
9 papers, 381 citations indexed

About

Preston D. Moore is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Preston D. Moore has authored 9 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Preston D. Moore's work include Advanced Breast Cancer Therapies (2 papers), HER2/EGFR in Cancer Research (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). Preston D. Moore is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), HER2/EGFR in Cancer Research (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). Preston D. Moore collaborates with scholars based in United States, Italy and South Korea. Preston D. Moore's co-authors include Violeta Sánchez, Mónica V. Estrada, Carlos L. Arteaga, Melinda E. Sanders, Kyung‐min Lee, Joshua A. Bauer, Michael J. Pishvaian, Teresa C. Dugger, Paula R. Pohlmann and Wenyi Wei and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Preston D. Moore

9 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Preston D. Moore United States 5 193 144 121 87 67 9 381
Yvonne E. Smith Ireland 9 185 1.0× 140 1.0× 228 1.9× 72 0.8× 130 1.9× 10 430
Ilsa Coleman United States 5 116 0.6× 114 0.8× 203 1.7× 99 1.1× 70 1.0× 7 433
Sara Koenig McLaughlin United States 4 141 0.7× 87 0.6× 337 2.8× 41 0.5× 133 2.0× 4 491
Leili Saeednejad Zanjani Iran 13 201 1.0× 102 0.7× 273 2.3× 74 0.9× 114 1.7× 37 497
Yong‐Jian Deng China 12 153 0.8× 44 0.3× 237 2.0× 68 0.8× 108 1.6× 21 424
Mou Peng China 12 119 0.6× 72 0.5× 174 1.4× 144 1.7× 85 1.3× 27 427
Maria Grazia Cipolleschi Italy 14 72 0.4× 31 0.2× 178 1.5× 74 0.9× 121 1.8× 21 436
Svetlana Miklikova Slovakia 12 168 0.9× 45 0.3× 202 1.7× 48 0.6× 117 1.7× 17 401
Kazunobu Isogaya Japan 12 180 0.9× 59 0.4× 427 3.5× 34 0.4× 98 1.5× 15 533
Suchitra Natarajan United States 8 130 0.7× 42 0.3× 226 1.9× 48 0.6× 126 1.9× 13 379

Countries citing papers authored by Preston D. Moore

Since Specialization
Citations

This map shows the geographic impact of Preston D. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Preston D. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Preston D. Moore more than expected).

Fields of papers citing papers by Preston D. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Preston D. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Preston D. Moore. The network helps show where Preston D. Moore may publish in the future.

Co-authorship network of co-authors of Preston D. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Preston D. Moore. A scholar is included among the top collaborators of Preston D. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Preston D. Moore. Preston D. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Defoe, Dennis M., et al.. (2020). A non-canonical role for p27Kip1 in restricting proliferation of corneal endothelial cells during development. PLoS ONE. 15(1). e0226725–e0226725. 4 indexed citations
2.
Im, S-A, Giuseppe Giaccone, Jeffrey L. Nordstrom, et al.. (2019). Abstract P6-18-11: Long-term responders to single-agent margetuximab, an Fc-modified anti-HER2 monoclonal antibody, in metastatic HER2+ breast cancer patients with prior anti-HER2 therapy. Cancer Research. 79(4_Supplement). P6–18. 2 indexed citations
3.
Jansen, Valerie M., Neil E. Bhola, Joshua A. Bauer, et al.. (2017). Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer. Cancer Research. 77(9). 2488–2499. 171 indexed citations
4.
Hanker, Ariella B., Mónica V. Estrada, Giampaolo Bianchini, et al.. (2017). Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer. Cancer Research. 77(12). 3280–3292. 78 indexed citations
5.
6.
Waddell, Amanda, Jefferson E. Vallance, Preston D. Moore, et al.. (2015). IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function. Inflammatory Bowel Diseases. 21(12). 2737–2746. 49 indexed citations
7.
Moore, Preston D., Gurunadh R. Chichili, Limin Huang, et al.. (2014). 138 Preclinical activity and safety of MGD006, a CD123xCD3 Bispecific DART® molecule for the treatment of hematological malignancies. European Journal of Cancer. 50. 48–48. 3 indexed citations
8.
Rosen, Michael J., Rupesh Chaturvedi, M. Kay Washington, et al.. (2013). STAT6 Deficiency Ameliorates Severity of Oxazolone Colitis by Decreasing Expression of Claudin-2 and Th2-Inducing Cytokines. The Journal of Immunology. 190(4). 1849–1858. 67 indexed citations
9.
Moore, Preston D., et al.. (2011). Accelerated turnover of taste bud cells in mice deficient for the cyclin-dependent kinase inhibitor p27Kip1. BMC Neuroscience. 12(1). 34–34. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yvonne E. Smith Breakdown of academic impact, for papers by Ilsa Coleman Breakdown of academic impact, for papers by Sara Koenig McLaughlin Breakdown of academic impact, for papers by Leili Saeednejad Zanjani Breakdown of academic impact, for papers by Yong‐Jian Deng Breakdown of academic impact, for papers by Mou Peng Breakdown of academic impact, for papers by Maria Grazia Cipolleschi Breakdown of academic impact, for papers by Svetlana Miklikova Breakdown of academic impact, for papers by Kazunobu Isogaya Breakdown of academic impact, for papers by Suchitra Natarajan
Rankless by CCL
2026